Work

Reduced-Dose Post-Transplant Cyclophosphamide (PTCy 40-40) in Allogeneic Hematopoietic Cell Transplantation

Year: 2026

Type: article

Study design: Observational Study

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.jtct.2026.08.041

Authors: Lauren Scarpetti, Qiuhong Zhao, Daniel Ikeda, Jeremy Sen, Jooho Chung, Zachariah DeFilipp, Areej El-Jawahri, Steve McAfee, Richard Newcomb, Gregory Novak, Paul O’Donnell, Thomas Spitzer, Sumithira Vasu, Gabriela Sanchez-Petitto, Nathan Denlinger, Jiasheng Wang, Marcos de Lima, Yi-Bin Chen, Hannah Choe

Institutions: NYU Langone Health, Mass General Brigham, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7204034040

FWCI: 4.973

Cites: 31

Cited by: 1

Related to: 10